April 6, 2017
Hikma, Jazz settle for Xyrem patent litigation
Hikma Pharmaceuticals and Jazz Pharmaceuticals have found a mutual language regarding a Jazz’s Xyrem patent litigation.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Hikma
March 15, 2017
Hikma’s profit affected by largest merger ever and more than doubling R&D investment. Confident in future prospects
Said Darwazah, Chairman and Chief Executive Officer of Hikma, said the 2016 was a year in which the company made “significant strategic progress”, reminding about the acquisition of West-Ward Columbus, the largest
October 12, 2016
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”
Hikma Pharmaceuticals has announced that Said Darwazah, Chairman and Chief Executive Officer of Hikma, received the “Leader of the Year Award” at the Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016.
December 28, 2015
Jochen Gann BI’s first director of Hikma
Hikma Board has appointed Dr. Jochen Gann as BI’s first nominated director.
November 18, 2015
Hikma’s Portugal facility in compliance with US FDA
Hikma’s Portuguese facility back into compliance with the US FDA.